Potential use of MDA-7 as a biological adjuvant for radiation therapy

Cancer Biology and Therapy

Volumn 3, Issue 8, 2004, Pages 752-754

  Shareef, Mohammed Momin ^a   Kokkinakis, Demetrius M ^d   Ahmed, Mansoor M ^a,b,c,e  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^e UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Gliobastoma; MDA 7; Radiosensitivity

Indexed keywords

CASPASE 8; CASPASE 9; CASPASE INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GLUTATHIONE TRANSFERASE; INTERLEUKIN 20; INTERLEUKIN 22; INTERLEUKIN 24; JANUS KINASE; MELANOMA DIFFERENTIATION ASSOCIATED 7 PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; PROTEIN P53; REACTIVE OXYGEN METABOLITE; STAT PROTEIN; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE 1; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; THIOREDOXIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN DERIVATIVE; INTERLEUKIN-24; RADIOSENSITIZING AGENT;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ASTROCYTE; BRAIN TUMOR; CANCER CELL; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CYTOREDUCTIVE SURGERY; CYTOTOXICITY; DRUG USE; GENE; GENE EXPRESSION; GENE MUTATION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; IONIZING RADIATION; LUNG CANCER; MEDULLOBLASTOMA; MELANOMA; MELANOMA CELL; NERVE CELL; NOTE; OXIDATIVE STRESS; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RADIATION EXPOSURE; SURVIVAL; SURVIVAL RATE; TUMOR CELL; UPREGULATION; VIRUS INFECTION; CELL PROLIFERATION; DRUG EFFECT; METABOLISM; TUMOR SUPPRESSOR GENE;

ADJUVANTS, IMMUNOLOGIC; APOPTOSIS; BRAIN NEOPLASMS; CELL PROLIFERATION; GENES, TUMOR SUPPRESSOR; HUMANS; INTERLEUKINS; RADIATION-SENSITIZING AGENTS;

EID: 16644399070     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.3.8.1029     Document Type: Note

References (28)

1. Muir CS, Storm HH, Polednak A. Brain and other nervous system tumours. Cancer Surv 1994; 19-20:369-92.
2. Avgeropoulos NG, Batchelor TT. New treatment strategies for malignant gliomas. Oncologist 1999; 4:209-24.
3. Silbergeld DL, Chicoine MR. Isolation and characterization of human malignant glioma cells from histologically normal brain. J Neurosurg 1997; 86:525-31.
4. Nieder C, Grosu AL, Molls M. A comparison of treatment results for recurrent malignant gliomas. Cancer Treat Rev 2000; 26:397-409.
5. Yacoub A, Mitchell C, Hong Y, Gopalkrishnan RV, Su ZZ, Gupta P, et al. MDA-7 regulates cell growth and radiosensitivity in vitro of primary (Nonestablished) human glioma cells. Cancer Biol Ther 2004; In press.
6. Jiang H, Lin JJ, Su ZZ, Goldstein NI, Fisher PB. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene 1995; 11:2477-86.
7. Fisher PB, Gopalkrishnan RV, Chada S, Ramesh R, Grimm EA, Rosengeld MR, et al. mda-7/IL-24, a novel cancer selective apoptosis inducing cytokine gene: from the laboratory into the clinic. Cancer Biol Ther 2003; 2:S23-37.
8. Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB. Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 2004; 22:929-79.
9. Huang EY, Madireddi MT, Gopalkrishnan RV, Leszczyniecka M, Su Z, Lebedeva IV, et al. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties. Oncogene 2001; 20:7051-63.
10. Saeki T, Mhashilkar A, Chada S, Branch C, Roth JA, Ramesh R. Tumor-suppressive effects by adenovirus-mediated mda-7 gene transfer in nonsmall cell lung cancer cell in vitro. Gene Ther 2000; 7:2051-7.
11. Su ZZ, Madireddi MT, Lin JJ, Young CS, Kitada S, Reed JC, et al. The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice. Proc Natl Acad Sci USA 1998; 95:14400-5.
12. Su Z, Lebedeva IV, Gopalkrishnan RV, Goldstein NI, Stein CA, Reed JC, et al. A combinatorial approach for selectively inducing programmed cell death in human pancreatic cancer cells. Proc Natl Acad Sci USA 2001; 98:10332-7.
13. Lebedeva IV, Su ZZ, Chang Y, Kitada S, Reed JC, Fisher PB. The cancer growth suppressing gene mda-7 induces apoptosis selectively in human melanoma cells. Oncogene 2002; 21:708-18.
14. Madireddi MT, Su ZZ, Young CS, Goldstein NI, Fisher PB. Mda-7, a novel melanoma differentiation associated gene with promise for cancer gene therapy. Adv Exp Med Biol 2000; 465:239-61.
15. Su ZZ, Lebedeva IV, Sarkar D, Gopalkrishnan RV, Sauane M, Sigmon C, et al. Melanoma differentiation associated gene-7, mda-7/IL-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53-independent manner. Oncogene 2003; 22:1164-80.
16. Ekmekcioglu S, Ellerhorst J, Mhashilkar AM, Sahin AA, Read CM, Prieto VG, et al. Down-regulated melanoma differentiation associated gene (mda-7) expression in human melanomas. Int J Cancer 2001; 94:54-9.
17. Wang M, Tan Z, Zhang R, Kotenko SV, Liang P. Interleukin 24 (MDA-7/MOB-5) signals through two heterodimeric receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2. J Biol Chem 2002; 277:7341-7.
18. Sauane M, Gopalkrishnan RV, Lebedeva I, Mei MX, Sarkar D, Su ZZ, et al. Mda-7/IL-24 induces apoptosis of diverse cancer cell lines through JAK/STAT-independent pathways. J Cell Physiol 2003; 196:334-45.
19. Kawabe S, Nishikawa T, Munshi A, Roth JA, Chada S, Meyn RE. Adenovirus-mediated mda-7 gene expression radiosensitizes nonsmall cell lung cancer cells via TP53-independent mechanisms. Mol Ther 2002; 6:637-44.
20. Yacoub A, Mitchell C, Lister A, Lebedeva IV, Sarkar D, Su ZZ, et al. Melanoma differentiation-associated 7 (interleukin 24) inhibits growth and enhances radiosensitivity of glioma cells in vitro and in vivo. Clin Cancer Res 2003; 9:3272-81.
21. Yacoub A, Mitchell C, Lebedeva IV, Sarkar D, Su ZZ, McKinstry R, et al. mda-7 (IL-24) Inhibits growth and enhances radiosensitivity of glioma cells in vitro via JNK signaling. Cancer Biol Ther 2003; 2:347-53.
22. Carter S, Auer KL, Reardon DB, Birrer M, Fisher PB, Valerie K, et al. Inhibition of the mitogen activated protein (MAP) kinase cascade potentiates cell killing by low dose ionizing radiation in A431 human squamous carcinoma cells. Oncogene 1998; 16:2787-96.
23. Reardon DB, Contessa JN, Mikkelsen RB, Valerie K, Amir C, Dent P, et al. Dominant negative EGFR-CD533 and inhibition of MAPK modify JNK1 activation and enhance radiation toxicity of human mammary carcinoma cells. Oncogene 1999; 18:4756-66.
24. Vrana JA, Grant S, Dent P. Inhibition of the MAPK pathway abrogates BCL2-mediated survival of leukemia cells after exposure to low-dose ionizing radiation. Radiat Res 1999; 151:559-69.
25. Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, et al. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. Embo J 1998; 17:2596-606.
26. Chen YR, Shrivastava A, Tan TH. Down-regulation of the c-Jun N-terminal kinase (JNK) phosphatase M3/6 and activation of JNK by hydrogen peroxide and pyrrolidine dithiocarbamate. Oncogene 2001; 20:367-74.
27. Bernardini S, Bernassola F, Cortese C, Ballerini S, Melino G, Motti C, et al. Modulation of GST P1-1 activity by polymerization during apoptosis. J Cell Biochem 2000; 77:645-53.
28. Saeki T, Mhashilkar A, Swanson X, Zou-Yang XH, Sieger K, Kawabe S, et al. Inhibition of human lung cancer growth following adenovirus-mediated mda-7 gene expression in vivo. Oncogene 2002; 21:4558-66.